Donaldson Capital Management, LLC Abb Vie Inc. Transaction History

Donaldson Capital Management, LLC

$2.38 Billion
Q2 2024

A detailed history of Donaldson Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Donaldson Capital Management, LLC holds 464,969 shares of ABBV stock, worth $89.2 Million. This represents 3.35% of its overall portfolio holdings.

Number of Shares

464,969

Previous 473,424 1.79%

Holding current value

$89.2 Million

Previous $86.2 Million 7.49%

% of portfolio

3.35%

Previous 3.59%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$154.79 - $180.76 $1.31 Million - $1.53 Million	-8,455 Reduced 1.79%	464,969 $79.8 Million
Q1 2024 Apr 22, 2024	BUY	$159.82 - $182.1 $355,439 - $404,990	2,224 Added 0.47%	473,424 $86.2 Million
Q4 2023 Jan 30, 2024	SELL	$137.6 - $154.97 $1.68 Million - $1.89 Million	-12,194 Reduced 2.52%	471,200 $73 Million
Q3 2023 Oct 11, 2023	BUY	$133.59 - $154.65 $723,657 - $837,739	5,417 Added 1.13%	483,394 $72.1 Million
Q2 2023 Jul 17, 2023	BUY	$132.51 - $164.9 $703,760 - $875,783	5,311 Added 1.12%	477,977 $64.4 Million
Q1 2023 Apr 13, 2023	BUY	$144.61 - $166.54 $418,790 - $482,299	2,896 Added 0.62%	472,666 $75.3 Million
Q4 2022 Feb 08, 2023	BUY	$138.31 - $165.87 $1.01 Million - $1.21 Million	7,287 Added 1.58%	469,770 $76 Million
Q3 2022 Oct 13, 2022	BUY	$134.21 - $153.93 $702,320 - $805,515	5,233 Added 1.14%	462,483 $62.1 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $13.7 Million - $17.4 Million	-99,622 Reduced 17.89%	457,250 $70 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $57,543 - $71,395	-436 Reduced 0.08%	556,872 $90.3 Million
Q4 2021 Jan 21, 2022	BUY	$107.43 - $135.93 $953,870 - $1.21 Million	8,879 Added 1.62%	557,308 $75.5 Million
Q3 2021 Nov 04, 2021	BUY	$106.4 - $120.78 $718,838 - $815,989	6,756 Added 1.25%	548,429 $59.2 Million
Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $1.26 Million - $1.4 Million	11,929 Added 2.25%	541,673 $61 Million
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $811,852 - $893,752	7,936 Added 1.52%	529,744 $57.3 Million
Q4 2020 Jan 11, 2021	SELL	$80.49 - $108.67 $103,912 - $140,292	-1,291 Reduced 0.25%	521,808 $55.9 Million
Q3 2020 Nov 02, 2020	SELL	$85.91 - $100.83 $963,652 - $1.13 Million	-11,217 Reduced 2.1%	523,099 $45.8 Million
Q2 2020 Jul 27, 2020	BUY	$73.37 - $98.18 $390,695 - $522,808	5,325 Added 1.01%	534,316 $52.5 Million
Q1 2020 Apr 16, 2020	BUY	$64.5 - $97.79 $2.32 Million - $3.52 Million	35,961 Added 7.29%	528,991 $40.3 Million
Q4 2019 Jan 14, 2020	BUY	$72.13 - $90.25 $800,138 - $1 Million	11,093 Added 2.3%	493,030 $43.7 Million
Q3 2019 Nov 04, 2019	BUY	$62.98 - $75.72 $6.35 Million - $7.63 Million	100,832 Added 26.46%	481,937 $36.5 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $584,795 - $747,505	8,901 Added 2.39%	381,105 $27.7 Million
Q1 2019 Apr 01, 2019	SELL	$77.14 - $90.79 $1.58 Million - $1.85 Million	-20,431 Reduced 5.2%	372,204 $30 Million
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $12,300 - $15,169	158 Added 0.04%	392,635 $36.2 Million
Q3 2018 Nov 06, 2018	SELL	$88.91 - $98.84 $110,781 - $123,154	-1,246 Reduced 0.32%	392,477 $37.1 Million
Q2 2018 Aug 07, 2018	SELL	$89.78 - $106.23 $405,266 - $479,522	-4,514 Reduced 1.13%	393,723 $36.5 Million
Q1 2018 Apr 30, 2018	SELL	$92.01 - $123.21 $1.18 Million - $1.58 Million	-12,812 Reduced 3.12%	398,237 $37.7 Million
Q4 2017 Jan 30, 2018	BUY	$89.56 - $98.21 $36 Million - $39.5 Million	402,245 Added 4568.89%	411,049 $39.8 Million
Q4 2017 Jan 26, 2018	SELL	$89.56 - $98.21 $36.6 Million - $40.2 Million	-409,068 Reduced 97.89%	8,804 $851,000
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $29.2 Million - $37.3 Million	417,872	417,872 $37.1 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $339B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Donaldson Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donaldson Capital Management, LLC with notifications on news.

Account

Donaldson Capital Management, LLC Abb Vie Inc. Transaction History